Graham Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $907K | Buy |
64,799
+21,794
| +51% | +$305K | 0.01% | 570 |
|
|
2025
Q1 | $585K | Buy |
43,005
+22,299
| +108% | +$303K | 0.01% | 713 |
|
|
2024
Q4 | $422K | Buy |
20,706
+8,941
| +76% | +$182K | 0.01% | 778 |
|
|
2024
Q3 | $343K | Buy |
+11,765
| New | +$343K | 0.01% | 708 |
|
|
2023
Q3 | – | Sell |
-31,611
| Closed | -$933K | – | 1056 |
|
|
2023
Q2 | $933K | Buy |
+31,611
| New | +$933K | 0.03% | 372 |
|